结直肠癌和EGFR基因突变的分子研究
Shayan Rasheed Abubakir1, Hazha Jamal Hidayat2
1Biology Department, College of Education, Salahaddin University-Erbil, Erbil, Iraq. shayan.abubaker@su.edu.krd.
Cellular and molecular biology (Noisy-le-Grand, France)
|October 9, 2023
概括
这项研究研究了结直肠癌患者表皮生长因子受体 (EGFR) 基因突变. 在分析的样本中,没有发现向EGFR外基因组 (18,19,20,21) 的突变.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 皮表皮生长因子受体 (EGFR) 途径的激活与人类瘤的发展有关.
- EGFR及其下游成分是抗癌疗法的关键标.
- 了解EGFR在结直肠癌发生中的作用对于治疗策略至关重要.
研究的目的:
- 评估EGFR通路对结直肠癌发生的影响.
- 在结肠直肠癌患者中研究EGFR基因特定表突变.
主要方法:
- 对1034名结肠直肠癌患者进行了一项医学调查.
- 实时PCR被用于分析EGFR基因突变在第18,19,20和21个表层.
- 从30个FFPE组织样本中提取DNA以检测突变.
主要成果:
- 对30名结肠直肠癌患者样本进行了分析.
- 在EGFR基因的向外子 (18,19,20,21) 中没有检测到任何突变.
- 与对照组实时PCR证实了这些特定地区没有突变.
结论:
- 这项研究没有发现研究结直肠癌队列中分析的EGFR外基因突变.
- 可能需要进一步的研究来探索其他EGFR区域或结直肠癌的途径.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


